Juan Carlos Jaramillo, Valneva CMO

Covid-19 roundup: UK au­tho­rizes 6th vac­cine with Val­neva's OK; FDA de­lays BLA for Re­gen­eron's halt­ed mAb com­bo

The UK’s drug reg­u­la­tor on Thurs­day be­came the first in the world to ap­prove Val­ne­va’s Covid-19 vac­cine, which be­comes the sixth Covid-19 vac­cine to be grant­ed an MHRA au­tho­riza­tion.

The French firm’s vac­cine is al­so the first whole-virus in­ac­ti­vat­ed Covid vac­cine to gain reg­u­la­to­ry ap­proval in the UK, the MHRA said. Un­like the mR­NA vac­cines from Pfiz­er and Mod­er­na, the pro­duc­tion of this in­ac­ti­vat­ed vac­cine is sim­i­lar to how the cur­rent flu and po­lio vac­cines are made.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.